Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A robust and versatile automated glycoanalytical technology for serum antibodies and acute phase proteins: ovarian cancer case study

ABSTRACT: N-glycoprofiles of IgG, IgM, IgA and transferrin, haptoglobin, alpha-1-antitrypsan in human serum

INSTRUMENT(S): Xevo G2-S Tof

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Roisin O'Flaherty

PROVIDER: MSV000083877 | MassIVE | Fri May 31 01:29:00 BST 2019

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study.

Project description: Not available

| S-EPMC6823853 | biostudies-literature

A fully-automated, robust, and versatile algorithm for long-term budding yeast segmentation and tracking.

Project description: Not available

| S-EPMC6436761 | biostudies-literature

Solution-phase automated synthesis of an ?-amino aldehyde as a versatile intermediate.

Project description: Not available

| S-EPMC5301908 | biostudies-literature

Micro RNA expression profiling using NanoString technology from IgA Nephropathy patients from Indian cohort.

Project description:The current study makes use of NanoString targeted technology to profile urinary exosomal miRNAs from IgA nephropathy affected patients and corresponding healthy controls. Circulatory biomarkers were detected for IgA nephropathy from Indian cohort which can be made used for the diagnostic therapy. 14 miRNAs were detected to be related to the disregulation in miRNome of IgA nephropathy patients using lasso feature selection method, out of which multiple miRNAs like hsa.mir.146b.3p, hsa.mir.599 and many more was resulted with high AUROC values >=0.9 efficient in differentiating between healthy controls and IgA nephropathy condition. These markers can be use further in the diagnosis and treatment of IgAN.

2023-12-13 | GSE244625 | GEO

Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries.

Project description: Not available

| S-EPMC438952 | biostudies-literature

Evaluation of TRAP-sequencing technology with a versatile conditional mouse model

Project description:Evaluation of TRAP-sequencing by comparing transcriptomes and translatomes of different organs and distinct cell populations. E14.5 brain and kidney transcriptome and translatome profiling of organs or distinct cell populations from these organs was performed using the Illumina TruSeq RNA technology.

2013-10-28 | E-GEOD-51619 | biostudies-arrayexpress

IgA transcytosis and tumor antigen recognition govern anti-tumor immunity in ovarian cancer

Project description:Although most ovarian cancers show prognostically relevant activated T-cell infiltrates, response rates to immune checkpoint inhibitors are very modest4. Memory B-cell and plasma cell infiltrates have been associated with better outcome in ovarian cancer, but the nature and functional relevance of these responses are controversial. Using 3 independent cohorts totaling 575 high-grade serous ovarian cancer (HGSOC) patients, we show that robust humoral responses are heavily dominated by the production of polyclonal IgA, which binds to Polymeric IgA Receptors universally expressed on ovarian cancer cells. Notably, all tertiary lymphoid structures identified in ~21% of HGSOCs contain IgA-producing oligoclonal B-cells. Strikingly, tumor Bcell-derived IgAs effectively target extracellular oncogenic drivers, whereas IgA transcytosis through malignant epithelial cells elicits transcriptional changes that antagonize the RAS pathway and that sensitize tumor cells to T-cell cytolytic killing, hindering malignant progression. Thus, tumor antigen-specific and antigen-independent IgA responses antagonize ovarian cancer growth by governing coordinated tumor cell, T-cell and B-cell responses. These findings provides a platform for the identification of novel targets spontaneously recognized by intratumoral B-cell-derived antibodies, and suggest that immunotherapies that augment B-cell responses may be more effective than T-cell-centric approaches, particularly for malignancies resistant to checkpoint inhibitors.

2020-12-01 | PXD018079 | Pride

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Project description: Not available

| S-EPMC7255167 | biostudies-literature

Evaluation of TRAP-sequencing technology with a versatile conditional mouse model

Project description:Evaluation of TRAP-sequencing by comparing transcriptomes and translatomes of different organs and distinct cell populations.

2013-10-28 | GSE51619 | GEO

HaloTag technology: a versatile platform for biomedical applications.

Project description: Not available

| S-EPMC4482335 | biostudies-other